Metastat Insights
Back to Healthcare

Global Aged Care Market

Global Aged Care Market Size, Share, By Care Setting (Residential Aged Care, Assisted Living and Senior Living Communities, Skilled Nursing and Post-Acute Care, Home-Based Aged Care), By Care Need (General Age-Related Support and Activities of Daily Living, Dementia and Alzheimer's Care, Chronic Disease Management, Post-Acute and Rehabilitation Care), By Age Group (60-74 Years, 75-84 Years, and 85 Years and Above), By Provider Ownership (For-Profit Private Providers, Not-for-Profit Providers, and Government and Public Providers), Industry Analysis, Growth, Trends, and Forecast, 2026-2033

Report ID

MSI-5013

Published

August 21, 2026

Updated

Pages

286 Pages

Format
Market Size 2021
$1,040.1 Billion

Historical

Market Size 2025
$1,360.4 Billion

Base year

Market Size 2033
$2,382.3 Billion

Forecast

CAGR 2025-2033
7.2%

Forecast period

Report Details

Comprehensive Market Analysis And Insights

End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

The Aged Care market size was valued at USD 1,360.4 billion in 2025.

The Aged Care market is projected to grow at a CAGR of 7.2% during the forecast period from 2026 to 2033.

The North America Aged Care market size is estimated to reach USD 875.5 billion by 2033.

Residential Aged Care leads the Aged Care market with a projected value of USD 345.9 billion by 2033, based on its growth trajectory compared to other segments.

The Aged Care market is primarily driven by the aging population, resulting in increased demand for care services. Lifestyle changes among older adults, including a preference for home-based care solutions, further influence this demand. strategic investments in innovative care models enhance service delivery and address the evolving needs of the elderly population.

North America holds the dominant share of the Aged Care market, with a value of USD 875.5 billion in 2033, representing 38.7 percent of the total market.

The Aged Care market growth faces significant restraints due to increased regulatory scrutiny, economic conditions, and resource scarcity. Compliance burdens raise operational costs, while inflation and supply chain disruptions create financial strain, impacting profitability and investment potential. These challenges hinder the ability to meet growing demand and achieve anticipated revenue targets.

Increasing demand for aged care services stems from the growing elderly population and shifting preferences towards home-based care solutions. The emphasis on innovation-led product diversification and the integration of technology enhance service delivery, attracting a broader customer base seeking high-quality care options.

The Aged Care market is estimated to reach a valuation of USD 2,382.3 billion by 2033.

Key players operating in the Aged Care market include Epoch Elder Care, St Luke's ElderCare Ltd., Amedisys (Optum), Encompass Health Corporation, Brookdale Senior Living Inc., BAYADA Home Health Care, and Home Instead, Inc.

About the Authors

UTKARSH KHIRODKAR

LEAD ANALYST

Aerospace and Defense · Agriculture · Automotive and Transportation · Banking & Finance · Biotechnology · Chemicals and Materials · Consumer Goods · Electronics and Semiconductor · Energy and Power · Food and Beverages · Healthcare · Healthcare IT · Information & Technology · Machinery & Equipment · Medical Devices · Packaging · Professional Services

AJAY DEVGIRE

LEAD PRINCIPAL ANALYST, PHARMA AND HEALTHCARE

Healthcare · Healthcare IT · Medical Devices

Last Updated: August 2026

What our clients say

Enterprise zero-trust network rollouts are often slowed down by multi-cloud transit latency and proprietary hardware retirement schedules. This study provided realistic total cost of ownership models comparing cloud-delivered security edge solutions against traditional hardware refreshes. The analysis of contract renewal lengths and software maintenance fees gave us clear visibility into enterprise replacement cycles over the next three to five years.
C

Cisco Systems

Technical Director

Scaling antibody-drug conjugate manufacturing hinges on contract manufacturing availability for high-potency active ingredients. The MetaStat Insight analysis looked closely at global cleanroom slot constraints, bioconjugation batch failure rates, and supply chain redundancies between the US, Europe, and India. The supplier capability matrix proved genuinely useful for our team when mapping secondary source options across our clinical pipeline.
A

AstraZeneca

Floating offshore wind feasibility relies heavily on specialized installation vessel availability and port crane limits, which most broad renewable energy forecasts ignore. The report delivered a thorough analysis of dry dock capacity, mooring chain supply constraints, and raw material pricing trends for deepwater anchor installations. It served as a solid independent sanity check for our offshore project capital expenditure assumptions.
S

Shell

Commercial Advisor, Offshore Wind Development

Related Reports

Explore related market intelligence reports worth reading alongside this one.